Givaudan | GIVN - Ebitda


Givaudan reported CHF778M in EBITDA for its fiscal semester ending in December of 2025.





Ebitda Change Date
Air Liquide EUR 3.82B 205.4M Dec/2025
Akzo Nobel EUR 345M 540M Mar/2026
Anheuser-Busch USD 5.44B 1.49B Mar/2026
Arkema EUR 282.7M 208.7M Mar/2026
Associated British Foods GBP 956M 136M Dec/2022
BASF EUR 2.36B 217M Mar/2026
Bayer EUR 4.45B 2.49B Mar/2026
Beiersdorf EUR 984M 147M Jun/2025
British American Tobacco GBP 6.02B 200M Jun/2024
Covestro EUR 117M 125M Dec/2025
Croda International GBP 198.5M 4.7M Jun/2025
Danone EUR 2.57B 116M Dec/2025
Diageo GBP 3.53B 229M Dec/2025
Fresenius EUR 951M 283M Mar/2026
Fresenius Medical Care EUR 824M 250M Mar/2026
Givaudan CHF 778M 195M Dec/2025
Glanbia EUR 289.7M 28.1M Jan/2025
Heineken EUR 2.93B 161M Dec/2025
Henkel EUR 1.88B 139M Dec/2024
International Flavors Fragrances USD 568M 260M Mar/2026
Johnson Matthey GBP 325M 52M Jun/2024
Kerry EUR 635.8M 83.6M Dec/2024
Lonza CHF 1.01B 54M Dec/2025
L'Oréal EUR 5.11B 489.1M Dec/2025
Merck EUR 1.53B 87M Mar/2026
Nestle CHF 9.09B 594M Jun/2025
Pernod Ricard EUR 2.18B 997M Dec/2024
Reckitt Benckiser GBP 1.95B 708M Jun/2025
SGS CHF 774M 78M Dec/2024
Sika AG CHF 994.3M 76.1M Dec/2025
Solvay EUR 219M 50M Mar/2026
Tate & Lyle GBP 200M 15M Jun/2026
Umicore EUR 414M 19M Dec/2025
Victrex GBP 49.1M 4M Dec/2023